NorthView Acquisition Corp (NVAC) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
Net income was -$35.8M, or -$10701.00 per diluted share. Operating activities generated -$16.2M of cash, leaving -$16.3M of free cash flow. At fiscal year end, NorthView Acquisition held $3.8M in total assets against $30.4M in total liabilities, including $1.8M of cash and equivalents.
Open the full interactive NorthView Acquisition financials → Quarterly statements, key ratios, valuation history and price charts.
NorthView Acquisition Key Stats
| Share Price | $1.28 |
|---|---|
| Market Cap | $73,825 |
| 52-Week Range | $1.28 – $2,415.00 |
| Shares Outstanding | 57,676 (basic, 2026 Q2) |
NorthView Acquisition Income Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — |
| Cost of Goods Sold | $0 | $0 | $0 | — |
| Gross Profit | $0 | $0 | $0 | — |
| Operating Income | -$1.3M | -$1.5M | -$1.4M | -$27.7M |
| Pre-Tax Income | $7.7M | $1.6M | -$8.6M | -$35.8M |
| Income Tax | $499,211 | $456,790 | $80,513 | — |
| Net Income | $7.2M | $1.2M | -$8.7M | -$35.8M |
| Diluted EPS | $2250.00 | $900.00 | -$11025.00 | -$10701.00 |
NorthView Acquisition Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | — | — | $0 | $0 |
| Net Income | -$22.2M | -$4.3M | -$3.5M | -$8.8M |
| Diluted EPS | -$5250.00 | -$12.89 | -$205.00 | -$151.80 |
NorthView Acquisition Balance Sheet
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash & Equivalents | — | $4,519 | $16,204 | $1.8M |
| Current Assets | $511,704 | $1.6M | $60,862 | $3.8M |
| Total Assets | $194.7M | $10.9M | $8.4M | $3.8M |
| Current Liabilities | $935,751 | $4.9M | $12.3M | $22.3M |
| Total Long-Term Debt | — | $3.4M | $1.9M | $12.1M |
| Total Liabilities | $1.8M | $5.1M | $13.0M | $30.4M |
| Shareholders' Equity | -$619,476 | -$3.5M | -$13.0M | -$26.7M |
NorthView Acquisition Cash Flow Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash From Operations | -$581,189 | -$2.1M | -$1.3M | -$16.2M |
| Cash From Investing | $33,447 | $185.6M | $3.0M | -$2.0M |
| Cash From Financing | — | -$183.7M | -$1.7M | $19.8M |
| Free Cash Flow | — | — | — | -$16.3M |
Figures from NorthView Acquisition's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full NorthView Acquisition financials page for every line item.
NorthView Acquisition Company Profile
| Ticker | NVAC |
|---|---|
| Exchange | Nasdaq, OTC |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001859807 |
Frequently Asked Questions
What is NorthView Acquisition's annual revenue history?
NorthView Acquisition's annual revenue by fiscal year: 2022: $0; 2023: $0; 2024: $0.
What was NorthView Acquisition's net income in fiscal 2025?
NorthView Acquisition reported net income of -$35.8M for fiscal 2025.
What was NorthView Acquisition's earnings per share (EPS) in fiscal 2025?
NorthView Acquisition's diluted EPS was -$10701.00 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did NorthView Acquisition generate in fiscal 2025?
NorthView Acquisition generated -$16.3M of free cash flow in fiscal 2025.
What was NorthView Acquisition's revenue last quarter?
In its most recent reported quarter (2026 Q2), NorthView Acquisition reported revenue of $0.
How much debt does NorthView Acquisition have?
NorthView Acquisition reported $12.1M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of NorthView Acquisition are outstanding?
NorthView Acquisition reported a weighted average of 57,676 basic shares outstanding in 2026 Q2.
What is NorthView Acquisition's market cap?
Based on its latest closing price, NorthView Acquisition (NVAC) has a market capitalization of about $73,825.
When does NorthView Acquisition's fiscal year end?
NorthView Acquisition's fiscal year end, as registered with the SEC, is December 31.
Where is NorthView Acquisition headquartered?
NorthView Acquisition lists its business address in New York, New York in its SEC filings.
NorthView Acquisition Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →